OmniaBio
Poornima Manavalan is currently serving as the Director of Business Development at OmniaBio. With a strong background in biotechnology and experience in various roles at companies like ElevateBio, FUJIFILM Diosynth Biotechnologies, FUJIFILM Irvine Scientific, Rubius Therapeutics, Massachusetts General Hospital, Shire, Merck Millipore, U.S. Department of Veterans Affairs, and GVK Biosciences, Poornima has demonstrated expertise in cell & gene therapy, research, and assay troubleshooting. Educationally, Poornima holds a Master's degree in Biological Sciences from the University of Massachusetts Lowell and a Bachelor of Technology in Biotechnology from Jawaharlal Nehru Technological University.
This person is not in any teams
This person is not in any offices
OmniaBio
OmniaBio Inc., a subsidiary of CCRM, launched July 1, 2022. OmniaBio is a contract development and manufacturing organization (CDMO) conducting process development and producing gene-modified cells and viral vectors for Phase I clinical trials to commercial-scale manufacturing. OmniaBio is bringing life-saving cell and gene therapies to patients in Canada and around the world.